Fri, Nov 11, 2016
The ongoing investigation by the US DoJ is likely to have limited impact on Indian pharma companies, said Fitch Ratings on Thursday.
More >
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.